Axactor ASA delivers significant growth and 12% return on equity for the second quarter excluding NRI's

Axactor delivers strong profit in Q2 2025, achieving a reported annualized return on equity of 8% and 12% excluding NRI's*. Key improvement factors include NPL collection performance of 102%, reduced financial expenses, and a solid 14% y-o-y revenue growth for the 3PC segment. Total revenue growth reached 8% y-o-y.

Financials

Key figures Q2 2025 (change from Q2 2024 in brackets)**

• Gross revenue of EUR 81m (down 9%, driven by portfolio sale in Spain)
• Total revenue of EUR 64m (up 8%)
• EBITDA of EUR 33m (up 7%)
• Cash EBITDA of EUR 50m (down 18%, driven by portfolio sale in Spain)
• Net profit after tax of EUR 7m (up EUR 3m)
• Reported annualized return on equity to shareholders of 8% (up 4pp) and 12% excluding NRI's*

“The curve adjustments we implemented in 2024 are affirmed by a 102% collection performance, and we are very pleased to deliver an all-time high return on equity to our shareholders in the first half of 2025,” says CEO Johnny Tsolis.

During the quarter Axactor successfully refinanced the RCF and the majority of the ACR03 bond. The ACR05 bond was placed at more than 3pp lower total interest rate compared to the most recent bond placement, ACR04.

“The successful refinancing completed in the second quarter provides greater financial flexibility to focus on investments that drive growth and build on the positive operational development achieved in recent quarters,” states Mr. Tsolis.

Presentation

10:00 am CEST, 14 August 2025: The results will be presented in a global investor webcast with a live Q&A session. A recording of the webcast will be made available here after the live session is concluded.

Participation will be possible via the options below. Please note that you need to register before you will be provided with access credentials.

Webcast:
> https://events.q4inc.com/attendee/176790542

Phone:
> https://www.netroadshow.com/events/login?show=b61ca4eb&confId=84597

Documents

> Quarterly Report - Q2 - 2025
> Axactor Q2-2025 Presentation

* NRI’s = Non-recurring items.

** EBITDA and other alternative performance measures (APMs) are defined and reconciled to the IFRS financial statements as a part of the APM section of the financial report.